Jaspreet Gill is the Executive Vice President, Global Quality Compliance for Akorn Pharmaceuticals reporting directly to the CEO of the company. In this role she is responsible for compliance of all Akorn manufacturing sites, corporate functions, CMOs and suppliers as well as due diligence for Business development opportunities. She is also responsible for Akorn India Quality Operations and leads the Quality council communications to the Akorn board on key quality compliance risks. Prior to joining Akorn in August 2014, she was the Vice President, Global Quality and Compliance in Corporate Quality for Baxter Healthcare. In this role she was responsible for design & deployment of the Baxter Global Quality system as well as assessment & monitoring of its effectiveness. The following functions reported to her: Corporate Compliance, Corporate Quality Systems, Global Supplier Quality, Regulatory Intelligence and the Strategic Program Management Office that managed global quality projects and monitored global quality metrics. Prior to joining Baxter in 2008, she was Director of Compliance at Johnson & Johnson where she held a variety of management positions for 10 years both in devices & pharmaceuticals. She has acquired over 24 years of experience in the FDA regulated industry. Her areas of compliance expertise include: OTC and pharmaceutical drugs, biologics, IVDs, medical devices & combination products. She is a member of the International Society for Pharmaceutical Engineering (ISPE), Parenteral Drug Association (PDA), American Society for Quality (ASQ) and Regulatory Affairs Professional Society (RAPS) and holds RAC and ASQ certifications.